Figure 4.
Progression-free survival based on Computer-Aided Nodule Assessment and Risk Yield Good, Intermediate, and Poor groups using low-dose computed tomography for patients diagnosed with adenocarcinoma during the National Lung Screening Trial. (A) All 294 cases. (B) All 218 pathologic stage I cases.